Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; Central nervous system infiltration; Intraventricular treatment;
مقالات ISI لوسمی لنفوسیتی مزمن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; Infections; Secondary cancers; Autoimmune diseases; Hypogammaglobulinemia;
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; guideline; lymphoma; rituximab; systematic review;
Keywords: لوسمی لنفوسیتی مزمن; ICER; incremental cost-effectiveness ratio; QALY; quality-adjusted life-year; ITC; indirect treatment comparison; Chronic lymphocytic leukaemia; Obinutuzumab; Chlorambucil; Rituximab; Ofatumumab; Cost-effectiveness; Costs;
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; Leukaemias; Lymphoproliferative disorders;
Keywords: لوسمی لنفوسیتی مزمن; Anti-cancer immunity; Immune regulation; NKT cells; MAIT cells; Regulatory T cells; Chronic lymphocytic leukaemia
Keywords: لوسمی لنفوسیتی مزمن; BMI; body mass index; Cas; cases; CLL; chronic lymphocytic leukaemia; ctrl; controls; DLBCL; diffuse large B-cell lymphoma; EPIC; European prospective investigation of diet and cancer; FL; follicular lymphoma; HCAs; heterocyclic amines; HL; Hodgkin lympho
Keywords: لوسمی لنفوسیتی مزمن; Outcomes research; Real-world; Chronic lymphocytic leukaemia; Observational study; Cost of illness; Costs;
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; Prognosis; Monocyte;
Is there an epidemic of chronic lymphocytic leukaemia (CLL) in China?
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; Incidence; Asia;
Un abcès du sein à Listeria chez un homme
Keywords: لوسمی لنفوسیتی مزمن; Abcès du sein; Listeria; Leucémie; Infiltrat cutané spécifique; Diabète; Chronic lymphocytic leukaemia; Specific cutaneous infiltrates; Listeria; Breast; Diabetes;
NF-κB in the crosshairs: Rethinking an old riddle
Keywords: لوسمی لنفوسیتی مزمن; BCL-2; B-cell lymphoma 2; BCL-XL; B-cell lymphoma-extra large; BFL-1; Bcl-2-related gene expressed in foetal liver; cIAP; cellular inhibitor of apoptosis; cFLIP; cellular FLICE-inhibitory protein; CLL; chronic lymphocytic leukaemia; DIABLO; direct inhibit
Elevated levels of follicular T helper cells and their association with therapeutic effects in patients with chronic lymphocytic leukaemia
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; Follicular T helper cells; Disease progression; Therapeutic effects; Flow cytometry;
ROS signalling in the biology of cancer
Keywords: لوسمی لنفوسیتی مزمن; AEJ; alternative end joining; ALL; acute lymphoblastic leukaemia; AML; acute myeloid leukaemia; Apaf-1; apoptotic protein activating factor 1; APL; acute promyelocytic leukaemia; ASK1; apoptosis signal regulating kinase 1; Bcr-Abl; breakpoint cluster-Abel
Differences between chronic lymphocytic leukaemia and small lymphocytic lymphoma cells by proteomic profiling and SNP microarray analysis
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; small lymphocytic lymphoma; chemokine receptors; DNA SNP microarrays; proteomic analysis;
Front-line treatment of CLL in the era of novel agents
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; First-line; Bruton's kinase inhibitor; Ibrutinib; Elderly; PI3Kδ inhibitor; Idelalisib; Venetoclax;
The 21st century revolution in CLL: Why this matters to patients
Keywords: لوسمی لنفوسیتی مزمن; CLL; Chronic lymphocytic leukaemia; Patients; Advocates; Clinical trials; Internet; CLLSociety.org; PatientPower.info; Novel therapies; Equipoise; Financial toxicity; Chemo-immunotherapy; Patient education and empowerment;
Present and future of personalized medicine in CLL
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; Personalized medicine; Next-generation sequencing; Prognostic factors; Predictive factors;
Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials
Keywords: لوسمی لنفوسیتی مزمن; Bendamustine; Rituximab; Chronic lymphocytic leukaemia; Therapy;
Regulation of B cell functions by Toll-like receptors and complement
Keywords: لوسمی لنفوسیتی مزمن; BCR; B cell receptor; TLRs; Toll-like receptors; CRs; complement receptors; PBMC; peripheral blood mononuclear cells; CLL; chronic lymphocytic leukaemia; RA; rheumatoid arthritis; SLE; systemic lupus erythematosus; B cells; Complement system; TLR; Crossta
Regulation of cell fate by lymphotoxin (LT) receptor signalling: Functional differences and similarities of the LT system to other TNF superfamily (TNFSF) members
Keywords: لوسمی لنفوسیتی مزمن; Lymphotoxin; CD40; Apoptosis; Receptor cross-linking; Cell signalling; AP-1; activator protein-1; APRIL; a proliferation-inducing ligand; BAFF; B-cell activating factor belonging to the TNF family; CLL; chronic lymphocytic leukaemia; DD; death domain; DR;
Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; Fludarabine; Cyclofosphamide
Chronic lymphocytic leukaemia cells become both activated and immunosuppressive following interaction with CD3 and CD28 stimulated PBMC
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; Activation; T-cell; Immunosuppression; Micro-environment;
Pro-apoptotic effect of an anti-CD37 scFv-Fc fusion protein, in combination with the anti-CD20 antibody, ofatumumab, on tumour cells from B-cell malignancies
Keywords: لوسمی لنفوسیتی مزمن; SMIP-016; TRU-016; Ofatumumab; Chronic lymphocytic leukaemia; B-cell malignancies;
Signals from activation of B-cell receptor with anti-IgD can override the stimulatory effects of excess BAFF on mature B cells in vivo
Keywords: لوسمی لنفوسیتی مزمن; BAFF; B-cell activating factor; BAFF-receptor; BAFF-R or BR3; BCMA; B cell maturation antigen; BCR; B-cell receptor; CD40L; CD40 ligand; CLL; chronic lymphocytic leukaemia; FcγRβII; Fc gamma receptor beta isoform II; HRP; horseradish peroxidase; mIgM; m
BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB
Keywords: لوسمی لنفوسیتی مزمن; BAFF; B cell-activating factor; BTK; Bruton's tyrosine kinase; CLL; chronic lymphocytic leukaemia; FLIP; FLICE (caspase-8)-like inhibitory protein; ibrutinib; 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-o
Proteomic analysis of B-cell receptor signaling in chronic lymphocytic leukaemia reveals a possible role for kininogen
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; B-cell receptor; Kininogen; Proteomics;
Cancer de la prostate et leucémie lymphoïde chronique
Keywords: لوسمی لنفوسیتی مزمن; Cancer de la prostate; Leucémie lymphoïde chronique; TraitementProstate cancer; Chronic lymphocytic leukaemia; Treatment
Leki immunomodulujÄ
ce - przeÅom w leczeniu nowotworów hematologicznych
Keywords: لوسمی لنفوسیتی مزمن; leki immunomodulujÄ
ce; szpiczak plazmocytowy; zespoÅy mielodysplastyczne; chÅoniaki nieziarnicze; przewlekÅa biaÅaczka limfocytowa; Immunomodulatory drugs; Multiple myeloma; Myelodysplastic syndromes; Non-Hogdkins' lymphomas; Chronic lymphocytic le
Leucémie lymphoïde chronique révélée par des infiltrats cutanés spécifiques en l'absence d'hyperlymphocytose : deux observations
Keywords: لوسمی لنفوسیتی مزمن; Leucémie lymphoïde chronique; Lymphome lymphocytique B; Infiltrat cutané; Localisation cutanée d'hémopathie; Hyperlymphocytose; Chronic lymphocytic leukaemia; Small lymphocytic lymphoma; Skin infiltration; Leukaemia cutis; Lymphocytosis;
Early ROS-mediated DNA damage and oxidative stress biomarkers in Monoclonal B Lymphocytosis
Keywords: لوسمی لنفوسیتی مزمن; Monoclonal B Lymphocytosis; Chronic lymphocytic leukaemia; Oxidative stress; 8-Oxo-dG; Antioxidants; DNA damage; F2-isoprostanes
Chronic Lymphocytic Leukaemia in the Netherlands: Trends in incidence, treatment and survival, 1989-2008
Keywords: لوسمی لنفوسیتی مزمن; Chronic Lymphocytic Leukaemia; Incidence; Survival; Epidemiology; Registries;
Metabolic signatures of cancer unveiled by NMR spectroscopy of human biofluids
Keywords: لوسمی لنفوسیتی مزمن; AL; acute leukaemia; Apo-IV and ApoA-I; apolipoproteins; AUC; area under curve; BE; Barret's esophagus; BMRB; Biological Magnetic Resonance Data Bank; BPH; benign prostatic hyperplasia; CA 19-9, CEA, CA 27.29; cancer antigens; CC; cholangiocarcinoma; CC
Apoptosis induces Bcl-XS and cleaved Bcl-XL in chronic lymphocytic leukaemia
Keywords: لوسمی لنفوسیتی مزمن; Apoptosis; Chronic lymphocytic leukaemia; Bcl-XL; Bcl-XS
Therapeutic management of chronic lymphocytic leukaemia: State of the art and future perspectives
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; Rituximab; Alemtuzumab; Stem cell transplantation; Purine nucleosides analogues; Non-myeloablative transplant
Electrochemotherapy treatment of a recalcitrant earlobe keloid scar with chronic lymphocytic leukaemia infiltration
Keywords: لوسمی لنفوسیتی مزمن; Keloid scar; Electrochemotherapy; Bleomycin; Chronic lymphocytic leukaemia;
High-dose methylprednisolone can induce remissions in patients with fludarabine-refractory chronic lymphocytic leukaemia
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; Methylprednisolone; Salvage therapy
T-cell function in chronic lymphocytic leukaemia
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; T-cell function; Antigen presentation; Lenalidomide; Tumour antigens
Dermatose éosinophilique associée aux hémopathies : étude clinique, histopathologique et immunohistochimique de six cas
Keywords: لوسمی لنفوسیتی مزمن; Dermatose éosinophilique associée aux hémopathies; Leucémie lymphoïde chronique; Lymphome du manteau; Piqûres d'insectes; Eosinophilic dermatosis associated with haematological disease; Chronic lymphocytic leukaemia; Mantle-cell lymphoma; Insect b
The role of the B-cell receptor in the pathogenesis of chronic lymphocytic leukaemia
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; B-cell receptor; Signalling; Anergy
Signalling to drug resistance in CLL
Keywords: لوسمی لنفوسیتی مزمن; chronic lymphocytic leukaemia; NF-κB; drug resistance
Is MRD eradication a desirable goal in CLL?
Keywords: لوسمی لنفوسیتی مزمن; chronic lymphocytic leukaemia; minimal residual disease
Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; Apoptosis; Inhibitor of apoptosis protein family; Prognosis
Strategy to induce apoptosis and circumvent resistance in chronic lymphocytic leukaemia
Keywords: لوسمی لنفوسیتی مزمن; chronic lymphocytic leukaemia; therapy; transcription inhibitor; translation inhibitor; cyclin-dependent kinase; anti-apoptotic proteins
Autoimmune Complications in Chronic Lymphocytic Leukaemia (CLL)
Keywords: لوسمی لنفوسیتی مزمن; chronic lymphocytic leukaemia; small lymphocytic lymphoma; autoimmune haemolytic anaemia; immune thrombocytopaenia; pure red blood cell aplasia
Chronic lymphocytic leukaemia: a disease of activated monoclonal B cells
Keywords: لوسمی لنفوسیتی مزمن; B lymphocyte; chronic lymphocytic leukaemia; cell proliferation; kinetics; antigen receptor; antigen
‘Indolent’ mature B-cell lymphomas
Keywords: لوسمی لنفوسیتی مزمن; chronic lymphocytic leukaemia; follicular lymphoma; hairy cell leukaemia; indolent B-cell lymphoma; MALT lymphoma; mantle cell leukaemia
Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD
Keywords: لوسمی لنفوسیتی مزمن; CPP; cell penetrating peptide; CLL; chronic lymphocytic leukaemia; CLSM; confocal laser scanning microscopy; PAD; proapoptotic domain; PBS; phosphate buffered saline; R8; octaarginine; Cell penetrating peptides; Octaarginine; Proapoptotic domain; Apoptosi
Glutamate dehydrogenase activity in lymphocytes of B-cell chronic lymphocytic leukaemia patients
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; Glutamate dehydrogenase; GLUD1 and GLUD2 gene expressions
Emerging therapies for patients with advanced chronic lymphocytic leukaemia
Keywords: لوسمی لنفوسیتی مزمن; Chronic lymphocytic leukaemia; Purine analogues; Monoclonal antibodies; Fludarabine-refractory; 17p Deletion